No Data
No Data
Theralase(R) Provides Update on Bladder Cancer Clinical Study
Theralase(R) Closes Non-Brokered Private Placement and Issues Stock Options
Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus
Theralase Technologies Inc. (TLTFF) Q2 2024 Earnings Call Transcript Summary
Theralase(R) Demonstrates Unique Ability to Activate Rutherrin(R) With Diabetes Drug
Theralase(R) Release's 2Q2024 Financial Statements
No Data